Novartis Initiates New Biomedical Research Hub in San Diego, Expanding Research Capabilities

Novartis has started constructing a new biomedical research center in San Diego, California, which will accommodate 1,000 employees and open in 2029. The facility aims to bolster the company's leadership in scientific innovation and develop groundbreaking treatments. Novartis exhibits strong financial health with robust revenue and profitability metrics, but its valuation metrics suggest a modestly overvalued position.